Services
Helping Pharma Industry with Digital, Data and Analytics with our value-based services
We help leading pharmaceutical, MEDtech and biotech companies transform Commercial and Medical Affairs functions with our end-to-end digital, data, and analytics services.
With tailored consulting, managed services, and digital transformation expertise, we drive evidence-based decision-making, global-to-local alignment, and measurable business and scientific impact. Our capabilities enable companies to anticipate market dynamics, shape strategic decision-making, and demonstrate scientific and commercial value across the product life cycle.
Commercial Services
Sales leaders & IT teams need to upgrade or optimize legacy CRM systems.
Faster go-live, higher adoption, cleaner data, and improved field productivity.
Commercial leaders & field teams need real-time visibility into HCP engagement and performance.
Smarter resource allocation, stronger HCP relationships, and data-driven insights.
Sales reps & MSL managers want to personalize HCP interactions and improve engagement quality.
Targeted outreach, optimized channel mix, and higher ROI from Commercial activities.
Market Access & KAM teams face challenges with payer access and account-level strategy.
Accelerate patient access, Optimized Account Strategy, Strategic Insights for Decision-Making
Medical Affairs Services
Achieve Enterprise-wide consistency and Improved decision Making
Accelerate time-to-market with real-time tracking of evidence needs and portfolio progress across all IEPs.
Teams often miss critical gaps because data lives in silos and teams can’t always identify which studies to start early to stay ahead of competitors.
Prioritize high-impact studies, eliminate redundancies, and reduce risk with a centralized evidence catalog for real-time visibility and proactive portfolio oversight.
Unify cross-functional stakeholders with one communication strategy— delivering tailored narratives, measurable scientific impact, and consistent messaging across the product lifecycle from pre-launch to sustain.
Stronger KOL relationships: Coordinated, high-quality interactions build trust and deepen engagement with key opinion leaders.
Faster evidence adoption: Consistent, well-aligned messaging
Unified view of past engagements and influence networks
Deeper advocacy: Blending proactive and reactive touchpoints ensures opinion leaders feel heard
Lost strategic insights? Valuable intelligence—Beliefs, Behaviors Ideas, and Thoughts —from KOL discussions often goes undocumented or remains siloed.
Limited visibility into KOL relationships? Teams lack a unified view of past interactions, affiliations, and influence networks to guide meaningful engagement.
Centralized planning and coordination
Stronger cross-functional alignment
Actionable intelligence: AI filters noise and delivers insights Monitor HCP, patient, and competitor conversations & sentiment pre-peri and post congresses
Limited visibility across teams? Without a centralized approach, it’s hard to track deliverables, align cross-functional stakeholders, or measure impact.
Too much noise, not enough insights? Teams struggle to cut through the volume of online chatter to find meaningful intelligence.
Missing the real-time pulse? Key HCP and competitor conversations at congresses often go unnoticed without dedicated social listening.
"You’re unsure how HCPs and the market perceive your science." Medical Affairs teams need sentiment intelligence.
Early detection of shifting HCP sentiment
Accelerate the uptake of new data and therapies.
Detect negative sentiment, competitor activity, and unmet needs from key social media platforms
Refine brand positioning, accelerate evidence adoption, and improve market impact.
Unsure who really drives the conversation? It’s challenging to pinpoint the high-impact HCPs, advocacy voices, and emerging digital opinion leaders shaping opinions online.
Missing real-time signals at major events? Negative sentiment, data gaps, or unmet needs often go undetected during congresses, drug launches, data releases, leading to missed opportunities for intervention.
No clear map of influence? Without understanding HCP networks and referral patterns, it’s difficult to identify clusters of influence or optimize engagement strategies.